Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis

References

• Kiffel J, Rahimzada Y, Trachtman H. Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients. Adv Chronic Kidney Dis 2011;18:332-8
   PubMed Web of Science ®Google Scholar
• Canaud G, Martinez F, Noel LH, et al. Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev (Orlando) 2010;24:121-8
   PubMedGoogle Scholar
• Braun N, Schmutzler F, Lange C, et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008;3:CD003233
   Google Scholar
• Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004;44:815-25
   PubMed Web of Science ®Google Scholar
• Gipson DS, Trachtman H, Kaskel FJ, et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 2011;80:868-78
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2012;2:139-274
   Web of Science ®Google Scholar
• Plank C, Kalb V, Hinkes B, et al. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr Nephrol 2008;23:1483-93
   PubMed Web of Science ®Google Scholar
• Ponticelli C, Rizzoni G, Edefonti A, et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993;43:1377-84
   PubMed Web of Science ®Google Scholar
• Hodson EM, Willis NS, Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev 2010;11:CD003594
   Google Scholar
• Cattran DC, Appel GB, Hebert LA, et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999;56:2220-6
   Google Scholar
• Garin EH, Orak JK, Hiott KL, et al. Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study. Am J Dis Child 1988;142:985-8
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94
   PubMed Web of Science ®Google Scholar
• Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002
   PubMed Web of Science ®Google Scholar
• Hogg RJ, Friedman A, Greene T, et al. Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol 2013;8:211-18
   PubMed Web of Science ®Google Scholar
• Cattran D, Neogi T, Sharma R, et al. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 2003;14:448-53
   PubMed Web of Science ®Google Scholar
• Lieberman KV, Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996;7:56-63
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to meta-analysis. Chichester, UK: John Wiley & Sons; 2008
   Google Scholar
• Wallace BC, Schmid CH, Lau J, et al. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009;9:80
   PubMed Web of Science ®Google Scholar
• Schwartz GJ, Brion LP, Spitzer A.The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-90
   PubMed Web of Science ®Google Scholar
• Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 2009;4:1832-43
   PubMed Web of Science ®Google Scholar
• Howman A, Chapman TL, Langdon MM, et al. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. Lancet 2013;381:744-51
   PubMed Web of Science ®Google Scholar
• Beer A, Mayer G, Kronbichler A. Treatment strategies of adult primary focal segmental glomerulosclerosis: a systematic review focusing on the last two decades. Biomed Res Int 2016;2016:4192578
   PubMed Web of Science ®Google Scholar
• Kronbichler A, Leierer J, Oh J, et al. Immunologic changes implicated in the pathogenesis of focal segmental glomerulosclerosis. Biomed Res Int 2016;2016:2150451
   PubMed Web of Science ®Google Scholar
• Mallat SG, Itani HS, Abou-Mrad RM, et al. Rituximab use in adult primary glomerulopathy: where is the evidence? Ther Clin Risk Manag 2016;291317-27
   Web of Science ®Google Scholar
• Coppo R. Different targets for treating focal segmental glomerular sclerosis. Contrib Nephrol 2013;181:84-90
   PubMed Web of Science ®Google Scholar
• Wakamatsu A, Fukusumi Y, Hasegawa E, et al. Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm. Physiol Rep 2016;4:e12679
   PubMed Web of Science ®Google Scholar
• Heering P, Braun N, Mullejans R, et al. German collaborative glomerulonephritis study group. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004;43:10-18
   PubMed Web of Science ®Google Scholar
• Sinha A, Sharma A, Mehta A, et al. Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome. Indian J Nephrol 2013;23:41-6
   PubMedGoogle Scholar
• Ren H, Shen P, Li X, et al. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. Am J Nephrol 2013;37:84-90
   PubMed Web of Science ®Google Scholar
• Duncan N, Dhaygude A, Owen J, et al. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant 2004;19:3062-7
   PubMed Web of Science ®Google Scholar
• Ramachandran R, Kumar V, Rathi M, et al. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience. Nephrol Dial Transplant 2014;29:1918-24
   PubMed Web of Science ®Google Scholar